{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:33:36Z","timestamp":1793028816049,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T00:00:00Z","timestamp":1232496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s00330-008-1280-7","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T03:08:19Z","timestamp":1232420899000},"page":"1425-1434","source":"Crossref","is-referenced-by-count":111,"title":["The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT"],"prefix":"10.1007","volume":"19","author":[{"given":"Mohsen","family":"Beheshti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"P\u00f6cher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Vali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Waldenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Broinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Kohlf\u00fcrst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pirich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Dralle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Langsteger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,21]]},"reference":[{"key":"1280_CR1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ssu.2980070209","volume":"7","author":"TC Lairmore","year":"1991","unstructured":"Lairmore TC, Wells SA Jr (1991) Medullary carcinoma of the thyroid: current diagnosis and management. Sem Surg Oncol 7:92\u201399","journal-title":"Sem Surg Oncol"},{"key":"1280_CR2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00005792-198411000-00001","volume":"63","author":"MF Saad","year":"1984","unstructured":"Saad MF, Ordonez NG, Rashid RK et al (1984) Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine 63:319\u2013342","journal-title":"Medicine"},{"key":"1280_CR3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/thy.1996.6.305","volume":"6","author":"J Brierley","year":"1996","unstructured":"Brierley J, Tsang R, Simpson WJ et al (1996) Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 6:305\u2013310","journal-title":"Thyroid"},{"key":"1280_CR4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11864-000-0052-7","volume":"1","author":"E Kebebew","year":"2000","unstructured":"Kebebew E, Clark OH (2000) Medullary thyroid cancer. Curr Treatm Opt Oncol 1:359\u2013367","journal-title":"Curr Treatm Opt Oncol"},{"key":"1280_CR5","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/1097-0142(20010501)91:9<1797::AID-CNCR1199>3.0.CO;2-P","volume":"91","author":"G Vitale","year":"2001","unstructured":"Vitale G, Caraglia M, Ciccarelli A et al (2001) Current approaches and perspectives in the therapy of medullary thyroid carcinoma. Cancer 91:1797\u20131808","journal-title":"Cancer"},{"key":"1280_CR6","first-page":"164","volume":"42","author":"C Hoang-Vu","year":"1992","unstructured":"Hoang-Vu C, Dralle H, Schroder S et al (1992) The nude rat is established as a model for endocrine studies: regulation of thyroid function and xenotransplantation of a thyroid tumor cell line. Lab Anim Sci 42:164\u2013167","journal-title":"Lab Anim Sci"},{"key":"1280_CR7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/erc.0.0080135","volume":"8","author":"F Orlandi","year":"2001","unstructured":"Orlandi F, Caraci P, Mussa A et al (2001) Treatment of medullary thyroid carcinoma: an update. Endocr Relat Cancer 8:135\u2013147","journal-title":"Endocr Relat Cancer"},{"key":"1280_CR8","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1158\/1078-0432.CCR-07-0935","volume":"13","author":"F Iten","year":"2007","unstructured":"Iten F, Muller B, Schindler C et al (2007) Response to [90yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial. Clin Cancer Res 13:6696\u20136702","journal-title":"Clin Cancer Res"},{"key":"1280_CR9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/00016480310015704","volume":"124","author":"EG Cohen","year":"2004","unstructured":"Cohen EG, Shaha AR, Rinaldo A et al (2004) Medullary thyroid carcinoma. Acta Otolaryngol 124:544\u2013557","journal-title":"Acta Otolaryngol"},{"key":"1280_CR10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/hed.20609","volume":"29","author":"JW Groot de","year":"2007","unstructured":"de Groot JW, Links TP, Sluiter WJ et al (2007) Locoregional control in patients with palpable medullary thyroid cancer: results of standardized compartment-oriented surgery. Head Neck 29:857\u2013863","journal-title":"Head Neck"},{"key":"1280_CR11","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/00000658-199906000-00016","volume":"229","author":"JF Moley","year":"1999","unstructured":"Moley JF, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229:880\u2013887 discussion 887\u2013888","journal-title":"Ann Surg"},{"key":"1280_CR12","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1210\/jc.2002-021713","volume":"88","author":"C Scollo","year":"2003","unstructured":"Scollo C, Baudin E, Travagli JP et al (2003) Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88:2070\u20132075","journal-title":"J Clin Endocrinol Metab"},{"key":"1280_CR13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2265.1998.00392.x","volume":"48","author":"E Modigliani","year":"1998","unstructured":"Modigliani E, Cohen R, Campos JM et al (1998) Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d\u2019etude des tumeurs a calcitonine. Clin Endocrinol 48:265\u2013273","journal-title":"Clin Endocrinol"},{"key":"1280_CR14","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa012915","volume":"349","author":"A Machens","year":"2003","unstructured":"Machens A, Niccoli-Sire P, Hoegel J et al (2003) Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349:1517\u20131525","journal-title":"N Engl J Med"},{"key":"1280_CR15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0003-4975(94)91091-X","volume":"58","author":"EC Bollen","year":"1994","unstructured":"Bollen EC, Goei R, van\u2019t Hof-Grootenboer BE et al (1994) Interobserver variability and accuracy of computed tomographic assessment of nodal status in lung cancer. Ann Thorac Surg 58:158\u2013162","journal-title":"Ann Thorac Surg"},{"key":"1280_CR16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1010-7940(97)00084-5","volume":"12","author":"A Gdeedo","year":"1997","unstructured":"Gdeedo A, Van Schil P, Corthouts B et al (1997) Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma. Eur J Cardiothorac Surg 12:224\u2013227","journal-title":"Eur J Cardiothorac Surg"},{"key":"1280_CR17","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s002590050296","volume":"25","author":"S Adams","year":"1998","unstructured":"Adams S, Baum RP, Hertel A et al (1998) Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings. Eur J Nucl Med 25:1277\u20131283","journal-title":"Eur J Nucl Med"},{"key":"1280_CR18","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/1097-0142(19871101)60:9<2189::AID-CNCR2820600913>3.0.CO;2-C","volume":"60","author":"JL Baulieu","year":"1987","unstructured":"Baulieu JL, Guilloteau D, Delisle MJ et al (1987) Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. A French cooperative study. Cancer 60:2189\u20132194","journal-title":"Cancer"},{"key":"1280_CR19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1677\/joe.0.1440339","volume":"144","author":"L Berna","year":"1911195","unstructured":"Berna L, Cabezas R, Mora J et al (1995) 111In-octreotide and 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma. J Endocrinol 144:339\u2013345","journal-title":"J Endocrinol"},{"key":"1280_CR20","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s002590050325","volume":"25","author":"L Berna","year":"1998","unstructured":"Berna L, Chico A, Matias-Guiu X et al (1998) Use of somatostatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinoma. Eur J Nucl Med. 25:1482\u20131488","journal-title":"Eur J Nucl Med."},{"key":"1280_CR21","first-page":"242","volume":"32","author":"U Guerra","year":"1988","unstructured":"Guerra U, Pizzocaro C, Terzi A et al (1988) The use of 99mTc(V)DMSA as imaging for the medullary thyroid carcinoma (MTC). J Nucl Med Allied Sci 32:242\u2013247","journal-title":"J Nucl Med Allied Sci"},{"key":"1280_CR22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00003072-199904000-00008","volume":"24","author":"Y Krausz","year":"1999","unstructured":"Krausz Y, Rosler A, Guttmann H et al (1999) Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid. Clin Nucl Med 24:256\u2013260","journal-title":"Clin Nucl Med"},{"key":"1280_CR23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00003072-199104000-00012","volume":"16","author":"OA Mojiminiyi","year":"1991","unstructured":"Mojiminiyi OA, Udelsman R, Soper ND et al (1991) Pentavalent Tc-99m DMSA scintigraphy. Prospective evaluation of its role in the management of patients with medullary carcinoma of the thyroid. Clin Nucl Med 16:259\u2013262","journal-title":"Clin Nucl Med"},{"key":"1280_CR24","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/BF01367593","volume":"23","author":"O Ugur","year":"1996","unstructured":"Ugur O, Kostakglu L, Guler N et al (1996) Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid. Eur J Nucl Med 23:1367\u20131371","journal-title":"Eur J Nucl Med"},{"key":"1280_CR25","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s002590050533","volume":"27","author":"K Brandt-Mainz","year":"2000","unstructured":"Brandt-Mainz K, Muller SP, Gorges R et al (2000) The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer. Eur J Nucl Med 27:490\u2013496","journal-title":"Eur J Nucl Med"},{"key":"1280_CR26","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1245\/ASO.2004.10.015","volume":"11","author":"JW Groot de","year":"2004","unstructured":"de Groot JW, Links TP, Jager PL et al (2004) Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer. Ann Surg Oncol 11:786\u2013794","journal-title":"Ann Surg Oncol"},{"key":"1280_CR27","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s002590100614","volume":"28","author":"M Diehl","year":"2001","unstructured":"Diehl M, Risse JH, Brandt-Mainz K et al (2001) Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study. Eur J Nucl Med 28:1671\u20131676","journal-title":"Eur J Nucl Med"},{"key":"1280_CR28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF03348014","volume":"20","author":"P Gasparoni","year":"1997","unstructured":"Gasparoni P, Rubello D, Ferlin G (1997) Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma. J Endocrinol Investig 20:527\u2013530","journal-title":"J Endocrinol Investig"},{"key":"1280_CR29","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0039-6060(97)90208-7","volume":"122","author":"TJ Musholt","year":"1997","unstructured":"Musholt TJ, Musholt PB, Dehdashti F et al (1997) Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study. Surgery 122:1049\u20131060; discussion 1060\u20131041","journal-title":"Surgery"},{"key":"1280_CR30","first-page":"66","volume":"43","author":"S Szakall Jr","year":"2002","unstructured":"Szakall S Jr, Esik O, Bajzik G et al (2002) 18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma. J Nucl Med 43:66\u201371","journal-title":"J Nucl Med"},{"key":"1280_CR31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0038-1629837","volume":"35","author":"GH Simon","year":"1996","unstructured":"Simon GH, Nitzsche EU, Laubenberger JJ et al (1996) PET imaging of recurrent medullary thyroid cancer. Nuklearmedizin 35:102\u2013104","journal-title":"Nuklearmedizin"},{"key":"1280_CR32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11307-006-0072-1","volume":"9","author":"A Iagaru","year":"2007","unstructured":"Iagaru A, Masamed R, Singer PA et al (2007) Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET and PET\/CT. Mol Imaging Biol 9:72\u201377","journal-title":"Mol Imaging Biol"},{"key":"1280_CR33","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1007\/s00259-007-0425-2","volume":"34","author":"B Beuthien-Baumann","year":"2007","unstructured":"Beuthien-Baumann B, Strumpf A, Zessin J et al (2007) Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 34:1604\u20131609","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1280_CR34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s002590000404","volume":"28","author":"S Hoegerle","year":"2001","unstructured":"Hoegerle S, Altehoefer C, Ghanem N et al (2001) 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med 28:64\u201371","journal-title":"Eur J Nucl Med"},{"issue":"Supplement 2","key":"1280_CR35","first-page":"138","volume":"48","author":"M Nader","year":"2007","unstructured":"Nader M, Eichinger R, Frey A (2007) Development and validation of a new analytical HPLC- method for the quality control of 6-[18F]fluoro-L-dopa. J Nucl Med; 48(Supplement 2):138","journal-title":"J Nucl Med;"},{"key":"1280_CR36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00000658-198404000-00014","volume":"199","author":"A Miyauchi","year":"1984","unstructured":"Miyauchi A, Onishi T, Morimoto S et al (1984) Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma. Ann Surg 199:461\u2013466","journal-title":"Ann Surg"},{"key":"1280_CR37","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2967\/jnumed.107.047720","volume":"49","author":"KP Koopmans","year":"2008","unstructured":"Koopmans KP, de Groot JW, Plukker JT et al (2008) 18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation. J Nucl Med 49:524\u2013531","journal-title":"J Nucl Med"},{"key":"1280_CR38","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2967\/jnumed.107.045708","volume":"49","author":"PL Jager","year":"2008","unstructured":"Jager PL, Chirakal R, Marriott CJ et al (2008) 6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications. J Nucl Med 49:573\u2013586","journal-title":"J Nucl Med"},{"key":"1280_CR39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2967\/jnumed.106.036681","volume":"48","author":"SC Ong","year":"2007","unstructured":"Ong SC, Schoder H, Patel SG et al (2007) Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels. J Nucl Med 48:501\u2013507","journal-title":"J Nucl Med"},{"key":"1280_CR40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1568009053202054","volume":"5","author":"S Li","year":"2005","unstructured":"Li S, Beheshti M (2005) The radionuclide molecular imaging and therapy of neuroendocrine tumors. Current Cancer Drug Targets 5:139\u2013148","journal-title":"Current Cancer Drug Targets"},{"key":"1280_CR41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1563-2571.2003.02045.x","volume":"30","author":"A Bockisch","year":"2003","unstructured":"Bockisch A, Brandt-Mainz K, Gorges R et al (2003) Diagnosis in medullary thyroid cancer with [18F]FDG-PET and improvement using a combined PET\/CT scanner. Acta Med Austriaca 30:22\u201325","journal-title":"Acta Med Austriaca"},{"key":"1280_CR42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00006231-200405000-00003","volume":"25","author":"M Gotthardt","year":"201804","unstructured":"Gotthardt M, Battmann A, Hoffken H et al (2004) 18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature. Nucl Med Common 25:439\u2013443","journal-title":"Nucl Med Common"},{"key":"1280_CR43","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/archotol.125.8.842","volume":"125","author":"Q Wang","year":"1999","unstructured":"Wang Q, Takashima S, Fukuda H et al (1999) Detection of medullary thyroid carcinoma and regional lymph node metastases by magnetic resonance imaging. Arch Otolaryngol Head Neck Surg 125:842\u2013848","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"1280_CR44","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0039-6060(05)80109-6","volume":"118","author":"WS Tung","year":"1995","unstructured":"Tung WS, Vesely TM, Moley JF (1995) Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer. Surgery 118:1024\u20131029; discussion 1029\u20131030","journal-title":"Surgery"},{"key":"1280_CR45","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/1097-0142(20010601)91:11<2084::AID-CNCR1236>3.0.CO;2-J","volume":"91","author":"O Esik","year":"2001","unstructured":"Esik O, Szavcsur P, Szakall S Jr et al (2001) Angiography effectively supports the diagnosis of hepatic metastases in medullary thyroid carcinoma. Cancer 91:2084\u20132095","journal-title":"Cancer"},{"key":"1280_CR46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002590050197","volume":"25","author":"S Adams","year":"1998","unstructured":"Adams S, Baum R, Rink T et al (1998) Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med 25:79\u201383","journal-title":"Eur J Nucl Med"},{"key":"1280_CR47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1055-3207(18)30230-8","volume":"8","author":"C James","year":"1999","unstructured":"James C, Starks M, MacGillivray DC et al (1999) The use of imaging studies in the diagnosis and management of thyroid cancer and hyperparathyroidism. Surg Oncol Clin N Am 8:145\u2013169","journal-title":"Surg Oncol Clin N Am"},{"key":"1280_CR48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00210956","volume":"71","author":"F Raue","year":"1993","unstructured":"Raue F, Kotzerke J, Reinwein D et al (1993) Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register. Clin Investig 71:7\u201312","journal-title":"Clin Investig"},{"key":"1280_CR49","first-page":"21","volume":"21","author":"NA Samaan","year":"1989","unstructured":"Samaan NA, Schultz PN, Hickey RC (1989) Medullary thyroid carcinoma: prognosis of familial versus nonfamilial disease and the role of radiotherapy. Horm Metab Res 21:21\u201325","journal-title":"Horm Metab Res"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-008-1280-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-008-1280-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-008-1280-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:54:40Z","timestamp":1559030080000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-008-1280-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,21]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["1280"],"URL":"https:\/\/doi.org\/10.1007\/s00330-008-1280-7","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,21]]}}}